{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:48:05Z","timestamp":1773359285172,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The increase in minimally invasive treatments (MITs) for lower urinary tract symptoms secondary to benign prostatic obstruction (LUTS\/BPO) has diversified surgical options, often outpacing solid evidence. The variety of available treatments, while beneficial, can confound physicians. Clinical guidelines provide direction but often differ due to varied evidence interpretation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We have analyzed the available guidelines on the surgical treatment of LUTS\/BPO updated within the last three years, focusing on those offering specific procedural recommendations. We compared recommendations, analyzed discrepancies, and developed a consensus algorithm that incorporated all pertinent advice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results and limitations<\/jats:title>\n            <jats:p>Out of 14 guidelines, four met the inclusion criteria. Major challenges were inconsistent nomenclature and a lack of clear recommendations, especially for newer procedures such as Temporary Implantable Nitinol Device (iTIND\u2122), Prostate Artery Embolization (PAE), Robotic Assisted Simple Prostatectomy (RASP), and Water Vapor Thermal Therapy (Rez\u016bm\u2122). Despite these issues, a consensus algorithm could be synthesized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions and clinical implications<\/jats:title>\n            <jats:p>Guidelines for the treatment of LUTS\/BPO present a disparate picture, with consensus mostly on older, well-established procedures due to substantial evidence. Newer interventions display significant variation in guideline recommendations and evidence interpretation. The consensus algorithm created from current guidelines offers a synthesized overview of recommendations, underscoring the need for standardized evidence criteria for guideline recommendations. Our work emphasizes the evolving complexity in LUTS\/BPO management, aiming to aid urologists in decision-making and patient counseling by providing a clear and comprehensive tool.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12894-025-01788-6","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T01:38:00Z","timestamp":1745458680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgical treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: an analysis and meta-synthesis of available guidelines"],"prefix":"10.1186","volume":"25","author":[{"given":"Laurenz S.","family":"Matter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Lyatoshinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Blarer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Abt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"1788_CR1","doi-asserted-by":"publisher","unstructured":"Berry SJ, Coffey DS, Walsh PC, Ewing LL. The Development of Human Benign Prostatic Hyperplasia with Age, Journal of Urology, 1984;132(3):474\u2013479 https:\/\/doi.org\/10.1016\/S0022-5347(17)49698-4","DOI":"10.1016\/S0022-5347(17)49698-4"},{"key":"1788_CR2","doi-asserted-by":"publisher","unstructured":"Sountoulides P, Karatzas A, Gravas S. Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction. Ther Adv Urol. 2019;11:175628721982897. https:\/\/doi.org\/10.1177\/1756287219828971","DOI":"10.1177\/1756287219828971"},{"key":"1788_CR3","doi-asserted-by":"publisher","unstructured":"Speakman MJ, et al. What is the required certainty of evidence for the implementation of novel techniques for the treatment of benign prostatic obstruction?? Eur Urol Focus. 2019;5(3):351\u20136. https:\/\/doi.org\/10.1016\/j.euf.2019.05.014","DOI":"10.1016\/j.euf.2019.05.014"},{"key":"1788_CR4","doi-asserted-by":"publisher","unstructured":"Touijer K. Marketing versus science: A fight between necessary evil and stern good over the adoption of new technology in medicine. Eur Urol. 2010;58(4):522\u20134. https:\/\/doi.org\/10.1016\/j.eururo.2010.06.004","DOI":"10.1016\/j.eururo.2010.06.004"},{"key":"1788_CR5","doi-asserted-by":"publisher","unstructured":"Murad L et al. Sep., Treating LUTS in Men with Benign Prostatic Obstruction: A Review Article, Drugs Aging, 2023;40(9):815\u2013836.https:\/\/doi.org\/10.1007\/s40266-023-01054-0","DOI":"10.1007\/s40266-023-01054-0"},{"key":"1788_CR6","doi-asserted-by":"publisher","unstructured":"Zumstein V, Betschart P, Abt D, Schmid H-P, Panje CM, Putora PM. Surgical management of urolithiasis \u2013 a systematic analysis of available guidelines. BMC Urol. Dec. 2018;18(1):25. https:\/\/doi.org\/10.1186\/s12894-018-0332-9","DOI":"10.1186\/s12894-018-0332-9"},{"key":"1788_CR7","unstructured":"Heesakkers J et al. Richtlijn Mannelijke niet-neurogene LUTS. https:\/\/www.nvu.nl\/kwaliteitsbeleid\/richtlijnen\/. Accessed: Nov. 15, 2023. [Online]. Available: https:\/\/www.nvu.nl\/kwaliteitsbeleid\/richtlijnen\/"},{"key":"1788_CR8","doi-asserted-by":"publisher","unstructured":"Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms\/Benign Prostatic Hyperplasia,. Singap Med J. Aug. 2017;58(8):473\u201380. https:\/\/doi.org\/10.11622\/smedj.2017082","DOI":"10.11622\/smedj.2017082"},{"key":"1788_CR9","unstructured":"Sabnis Ravindra B, Mulawkar Prashant, Rohit J, Guidelines on Management of BPH\/ BPO., https:\/\/usi.org.in\/page.php?pid=27. Accessed: Nov. 15, 2023. [Online]. Available: https:\/\/usi.org.in\/pdf\/BPH_Indian_Guidelines_Final_Website.pdf"},{"key":"1788_CR10","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Ramos H, Latorre C, Pati\u00f1o G, Arenas J. Erratum: Gu\u00eda de Manejo hiperplasia prost\u00e1tica Benigna (SCU 2021). Revista Urolog\u00eda Colombiana \/ Colombian Urol J. Jun. 2021;30(02):e1\u20132. https:\/\/doi.org\/10.1055\/s-0041-1732337","DOI":"10.1055\/s-0041-1732337"},{"key":"1788_CR11","doi-asserted-by":"publisher","unstructured":"Sandhu JS et al. Jan., Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023, Journal of Urology, 2024;211(1):11\u201319. https:\/\/doi.org\/10.1097\/JU.0000000000003698","DOI":"10.1097\/JU.0000000000003698"},{"key":"1788_CR12","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris ISBN 978-94-92671-23-3, Paris, 2024."},{"key":"1788_CR13","doi-asserted-by":"publisher","unstructured":"Elterman D et al. UPDATE\u2013., 2022 Canadian Urological Association guideline on male lower urinary tract symptoms\/benign prostatic hyperplasia (MLUTS\/BPH), Canadian Urological Association Journal, 2022;16(8). https:\/\/doi.org\/10.5489\/cuaj.7906","DOI":"10.5489\/cuaj.7906"},{"key":"1788_CR14","unstructured":"Deutsche Gesellschaft f\u00fcr Urologie e. V. (Hrsg.): S2e-Leitlinie Diagnostik undTherapie des Benignen Prostatasyndroms (BPS), Langversion 5.0, 2023, AWMFRegisternummer: 043-034. https:\/\/www.urologenportal.de\/fachbesucher\/wirueberuns\/dgu\/leitlinien-der-deutschen-gesellschaft-fuer-urologie.html"},{"key":"1788_CR15","doi-asserted-by":"publisher","unstructured":"Ditonno F et al. Sep., Benign Prostatic Hyperplasia Surgery: A Snapshot of Trends, Costs, and Surgical Retreatment Rates in the USA, Eur Urol Focus, 2024;10(5):826\u2013832. https:\/\/doi.org\/10.1016\/j.euf.2024.04.006","DOI":"10.1016\/j.euf.2024.04.006"},{"key":"1788_CR16","doi-asserted-by":"publisher","unstructured":"Lenzer J, Hoffman JR, Furberg CD, Ioannidis JPA. Ensuring the integrity of clinical practice guidelines: a tool for protecting patients. BMJ. p. f 2013;5535. https:\/\/doi.org\/10.1136\/bmj.f5535","DOI":"10.1136\/bmj.f5535"},{"key":"1788_CR17","doi-asserted-by":"publisher","unstructured":"Norris SL, Holmer HK, Ogden LA, Burda BU. Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review, PLoS One, 2011;6(10):e25153. https:\/\/doi.org\/10.1371\/journal.pone.0025153","DOI":"10.1371\/journal.pone.0025153"},{"key":"1788_CR18","doi-asserted-by":"publisher","unstructured":"Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. Jul. 2017;390(10092):415\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(16)31592-6","DOI":"10.1016\/S0140-6736(16)31592-6"},{"key":"1788_CR19","doi-asserted-by":"publisher","unstructured":"Djulbegovic B, Guyatt G. Evidence vs consensus in clinical practice guidelines. JAMA. 2019;322(8):725. https:\/\/doi.org\/10.1001\/jama.2019.9751","DOI":"10.1001\/jama.2019.9751"},{"key":"1788_CR20","doi-asserted-by":"publisher","DOI":"10.17226\/13058","volume-title":"Clinical practice guidelines we can trust","year":"2011","unstructured":"Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, editors. Clinical practice guidelines we can trust. Washington, D.C.: National Academies. 2011. https:\/\/doi.org\/10.17226\/13058"},{"issue":"1","key":"1788_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000517675","volume":"106","author":"D Enikeev","year":"2022","unstructured":"Enikeev D, et al. EAU, AUA and NICE guidelines on surgical and minimally invasive treatment of benign prostate hyperplasia: A critical appraisal of the guidelines using the AGREE-II tool. Urol Int. 2022;106(1):1\u201310. https:\/\/doi.org\/10.1159\/000517675","journal-title":"Urol Int"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01788-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T01:38:05Z","timestamp":1745458685000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01788-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01788-6","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No people involved. This study solely analyzes written guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}